Compounds > rhein
Page last updated: 2024-08-21

rhein and Breast Neoplasms

rhein has been researched along with Breast Neoplasms in 7 studies

Research

Studies (7)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (28.57)29.6817
2010's4 (57.14)24.3611
2020's1 (14.29)2.80

Authors

AuthorsStudies
Chen, R; Di, L; Hu, L; Huang, J; Li, J; Wang, H; Wang, R; Yang, M; Yang, Y; Yuan, D1
Bian, L; Duan, X; Feng, Y; Gao, M; Huang, D; Ji, A; Jin, Q; Luo, Q; Ni, Y; Su, C; Yin, Z; Zhang, D; Zhang, J1
Chan, HL; Chen, YW; Chou, HC; Huang, HJ; Lin, CC; Lin, DY; Lin, ST; Lin, YC; Lyu, KW1
Ho, CT; Hung, CM; Kao, JY; Lin, YC; Ma, JW; Way, TD1
Huang, YH; Lin, YJ; Liu, XJ; Zhen, YS; Zhen, YZ1
Lin, YJ; Zhen, YS1
Bwambok, DK; Fakayode, SO; Fernand, VE; Losso, JN; Lowry, M; Truax, RE; Villar, EE; Warner, IM1

Other Studies

7 other study(ies) available for rhein and Breast Neoplasms

ArticleYear
Synergistic inhibition of metastatic breast cancer by dual-chemotherapy with excipient-free rhein/DOX nanodispersions.
    Journal of nanobiotechnology, 2020, Aug-26, Volume: 18, Issue:1

    Topics: Animals; Anthraquinones; Antineoplastic Agents; Apoptosis; Breast Neoplasms; Cell Line, Tumor; Cell Proliferation; Doxorubicin; Drug Synergism; Female; Mice; Nanoparticles

2020
Synthesis and Biological Evaluation of Rhein-Based MRI Contrast Agents for in Vivo Visualization of Necrosis.
    Analytical chemistry, 2018, 11-20, Volume: 90, Issue:22

    Topics: Animals; Anthraquinones; Breast Neoplasms; Carcinoma; Cell Line, Tumor; Contrast Media; Copper Radioisotopes; DNA; Heterocyclic Compounds; Humans; Infarction; Intercalating Agents; Liver; Magnetic Resonance Imaging; Male; Muscles; Necrosis; Organometallic Compounds; Rats, Sprague-Dawley; Reperfusion Injury

2018
Proteomic analysis of rhein-induced cyt: ER stress mediates cell death in breast cancer cells.
    Molecular bioSystems, 2014, Volume: 10, Issue:12

    Topics: Acetylcysteine; Angiogenesis Inhibitors; Anthraquinones; Breast Neoplasms; Cell Death; Cell Line, Tumor; Cell Survival; Endoplasmic Reticulum Stress; Female; Humans; MCF-7 Cells; Oxidation-Reduction; Proteomics; Reactive Oxygen Species; Reproducibility of Results; Rheum; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization; Two-Dimensional Difference Gel Electrophoresis

2014
Aloe-emodin inhibits HER-2 expression through the downregulation of Y-box binding protein-1 in HER-2-overexpressing human breast cancer cells.
    Oncotarget, 2016, Sep-13, Volume: 7, Issue:37

    Topics: Anthraquinones; Breast Neoplasms; Carcinogenesis; Cell Movement; Down-Regulation; Emodin; Female; Glucosides; Humans; Neoplasm Metastasis; Phytotherapy; Plant Roots; Proto-Oncogene Proteins c-akt; Receptor, ErbB-2; Rheum; Signal Transduction; TOR Serine-Threonine Kinases; Tumor Cells, Cultured; Y-Box-Binding Protein 1

2016
[Rhein lysinate induces apoptosis in breast cancer SK-Br-3 cells by inhibiting HER-2 signal pathway].
    Yao xue xue bao = Acta pharmaceutica Sinica, 2008, Volume: 43, Issue:11

    Topics: Anthraquinones; Antineoplastic Agents; Apoptosis; Breast Neoplasms; Cell Line, Tumor; Cell Proliferation; Cyclin-Dependent Kinase Inhibitor p21; Female; Humans; Inhibitory Concentration 50; Lysine; NF-kappa B; Receptor, ErbB-2; RNA, Messenger; Signal Transduction; Tumor Suppressor Protein p53

2008
Rhein lysinate suppresses the growth of breast cancer cells and potentiates the inhibitory effect of Taxol in athymic mice.
    Anti-cancer drugs, 2009, Volume: 20, Issue:1

    Topics: Animals; Anthraquinones; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cell Line, Tumor; Cell Proliferation; Dose-Response Relationship, Drug; Drug Synergism; ErbB Receptors; Extracellular Signal-Regulated MAP Kinases; Female; Humans; Inhibitory Concentration 50; Lysine; Mice; Mice, Inbred BALB C; Mice, Nude; Mitogen-Activated Protein Kinase Kinases; Paclitaxel; Phosphorylation; Proto-Oncogene Proteins c-raf; ras Proteins; Signal Transduction; Time Factors; Xenograft Model Antitumor Assays

2009
Rhein inhibits angiogenesis and the viability of hormone-dependent and -independent cancer cells under normoxic or hypoxic conditions in vitro.
    Chemico-biological interactions, 2011, Jul-15, Volume: 192, Issue:3

    Topics: Angiogenesis Inhibitors; Anthraquinones; Anticarcinogenic Agents; Breast Neoplasms; Cell Cycle; Cell Line, Tumor; Cell Movement; Cell Proliferation; Cell Survival; Cyclooxygenase 2; Female; HSP90 Heat-Shock Proteins; Humans; Hypoxia-Inducible Factor 1, alpha Subunit; Mitogen-Activated Protein Kinases; Neoplasm Invasiveness; Neoplasms, Hormone-Dependent; NF-kappa B; Phosphatidylinositol 3-Kinase; Proto-Oncogene Proteins c-akt; Vascular Endothelial Growth Factor A

2011